title: Adverse cutaneous reactions to interferon alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus.
authors.forename: J A
authors.initials: JA
authors.lastname: Manjón-Haces
authors.forename: F
authors.initials: F
authors.lastname: Vázquez-López
authors.forename: S
authors.initials: S
authors.lastname: Gómez-Díez
authors.forename: A
authors.initials: A
authors.lastname: Hidalgo-García
authors.forename: R
authors.initials: R
authors.lastname: Pérez-Alvarez
authors.forename: T
authors.initials: T
authors.lastname: Soler-Sánchez
authors.forename: N
authors.initials: N
authors.lastname: Pérez-Oliva
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000473:pathology; D004359:Drug Therapy, Combination; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012254:Ribavirin / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D012254:Ribavirin